These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38203769)

  • 1. Development of a Novel Biomarker for the Progression of Idiopathic Pulmonary Fibrosis.
    Yeo HJ; Ha M; Shin DH; Lee HR; Kim YH; Cho WH
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
    Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
    Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
    Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.
    Molyneaux PL; Fahy WA; Byrne AJ; Braybrooke R; Saunders P; Toshner R; Albers G; Chua F; Renzoni EA; Wells AU; Karkera Y; Oballa E; Saini G; Nicholson AG; Jenkins RG; Maher TM
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1440-1448. PubMed ID: 35363592
    [No Abstract]   [Full Text] [Related]  

  • 6. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
    Maher TM; Oballa E; Simpson JK; Porte J; Habgood A; Fahy WA; Flynn A; Molyneaux PL; Braybrooke R; Divyateja H; Parfrey H; Rassl D; Russell AM; Saini G; Renzoni EA; Duggan AM; Hubbard R; Wells AU; Lukey PT; Marshall RP; Jenkins RG
    Lancet Respir Med; 2017 Dec; 5(12):946-955. PubMed ID: 29150411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
    Akiyama N; Hozumi H; Isayama T; Okada J; Sugiura K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respirology; 2020 Jul; 25(7):743-749. PubMed ID: 31597225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
    DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
    Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
    Hozumi H; Kataoka K; Kondoh Y; Isayama T; Okada J; Sugiura K; Mori K; Kono M; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chest; 2021 Dec; 160(6):2149-2157. PubMed ID: 34252438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
    Niwamoto T; Handa T; Murase Y; Nakatsuka Y; Tanizawa K; Taguchi Y; Tomioka H; Tomii K; Kita H; Uyama M; Tsuchiya M; Emura M; Kawamura T; Arai N; Arita M; Uno K; Yoshizawa A; Uozumi R; Yamaguchi I; Matsuda F; Chin K; Hirai T
    Respir Res; 2021 Jun; 22(1):181. PubMed ID: 34158044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis.
    Jessen H; Hoyer N; Prior TS; Frederiksen P; Rønnow SR; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB
    BMC Pulm Med; 2021 Nov; 21(1):382. PubMed ID: 34814865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker signatures for progressive idiopathic pulmonary fibrosis.
    Clynick B; Corte TJ; Jo HE; Stewart I; Glaspole IN; Grainge C; Maher TM; Navaratnam V; Hubbard R; Hopkins PMA; Reynolds PN; Chapman S; Zappala C; Keir GJ; Cooper WA; Mahar AM; Ellis S; Goh NS; De Jong E; Cha L; Tan DBA; Leigh L; Oldmeadow C; Walters EH; Jenkins RG; Moodley Y
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34675050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis.
    Jessen H; Hoyer N; Prior TS; Frederiksen P; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB
    Respir Res; 2021 Jul; 22(1):205. PubMed ID: 34261485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).
    Boon K; Bailey NW; Yang J; Steel MP; Groshong S; Kervitsky D; Brown KK; Schwarz MI; Schwartz DA
    PLoS One; 2009; 4(4):e5134. PubMed ID: 19347046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
    Jenkins RG; Simpson JK; Saini G; Bentley JH; Russell AM; Braybrooke R; Molyneaux PL; McKeever TM; Wells AU; Flynn A; Hubbard RB; Leeming DJ; Marshall RP; Karsdal MA; Lukey PT; Maher TM
    Lancet Respir Med; 2015 Jun; 3(6):462-72. PubMed ID: 25770676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.
    Maldonado M; Buendía-Roldán I; Vicens-Zygmunt V; Planas L; Molina-Molina M; Selman M; Pardo A
    PLoS One; 2018; 13(9):e0203779. PubMed ID: 30208119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts.
    Machahua C; Guler SA; Horn MP; Planas-Cerezales L; Montes-Worboys A; Geiser TK; Molina-Molina M; Funke-Chambour M
    BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33451989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis.
    Huang G; Xu X; Ju C; Zhong N; He J; Tang XX
    Front Immunol; 2022; 13():997138. PubMed ID: 36211385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.
    Vukmirovic M; Herazo-Maya JD; Blackmon J; Skodric-Trifunovic V; Jovanovic D; Pavlovic S; Stojsic J; Zeljkovic V; Yan X; Homer R; Stefanovic B; Kaminski N
    BMC Pulm Med; 2017 Jan; 17(1):15. PubMed ID: 28081703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100 Calcium-Binding Protein A9, a Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis.
    Lee JU; Kim MK; Kim MS; Lee SJ; Park SL; Chang HS; Park JS; Park CS
    J Korean Med Sci; 2024 Jan; 39(1):e13. PubMed ID: 38193329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.